PMV Pharmaceuticals, Inc.
PMVP
$1.27
$0.043.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.73% | 8.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.56% | 6.10% | |||
| Operating Income | 1.56% | -6.10% | |||
| Income Before Tax | 0.66% | -8.01% | |||
| Income Tax Expenses | -220.00% | 100.23% | |||
| Earnings from Continuing Operations | 0.71% | -21.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.71% | -21.64% | |||
| EBIT | 1.56% | -6.10% | |||
| EBITDA | 1.56% | -6.13% | |||
| EPS Basic | 2.55% | -21.51% | |||
| Normalized Basic EPS | 2.51% | -7.87% | |||
| EPS Diluted | 2.55% | -21.51% | |||
| Normalized Diluted EPS | 2.51% | -7.87% | |||
| Average Basic Shares Outstanding | 1.89% | 0.11% | |||
| Average Diluted Shares Outstanding | 1.89% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||